Results 21 to 30 of about 97,918 (341)

Nanomedicine

open access: yesOpen Schools Journal for Open Science, 2020
Important and life-sustaining processes such as teh uptake, transport and metabolism of biologicla substances take place on cellular level in the human body. Diseases and disorders happening on this level can now be targeted with diagnostic and threapeutic tools in the nano-scaled size range.
Winkler, L.   +4 more
openaire   +4 more sources

Fucoidans in Nanomedicine [PDF]

open access: yesMarine Drugs, 2016
Fucoidans are widespread cost-effective sulfated marine polysaccharides which have raised interest in the scientific community over last decades for their wide spectrum of bioactivities. Unsurprisingly, nanomedicine has grasped these compounds to develop innovative therapeutic and diagnostic nanosystems. The applications of fucoidans in nanomedicine as
Chollet, Lucas   +5 more
openaire   +5 more sources

Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials

open access: yesMolecules, 2023
Cancer continues to pose a severe threat to global health, making pursuing effective treatments more critical than ever. Traditional therapies, although pivotal in managing cancer, encounter considerable challenges, including drug resistance, poor drug ...
Manman Xu   +6 more
semanticscholar   +1 more source

Personalized Nanomedicine [PDF]

open access: yesClinical Cancer Research, 2012
Abstract Personalized medicine aims to individualize chemotherapeutic interventions on the basis of ex vivo and in vivo information on patient- and disease-specific characteristics. By noninvasively visualizing how well image-guided nanomedicines—that is, submicrometer-sized drug delivery systems containing both drugs and imaging agents ...
Lammers, T.   +3 more
openaire   +4 more sources

Oral polyphenol-armored nanomedicine for targeted modulation of gut microbiota–brain interactions in colitis

open access: yesScience Advances, 2023
Developing oral nanomedicines that suppress intestinal inflammation while modulating gut microbiota and brain interactions is essential for effectively treating inflammatory bowel disease.
Huang He   +8 more
semanticscholar   +1 more source

Roadmap on nanomedicine

open access: yesNanotechnology, 2020
Since the launch of the Alliance for Nanotechnology in Cancer by the National Cancer Institute in late 2004, several similar initiatives have been promoted all over the globe with the intention of advancing the diagnosis, treatment and prevention of cancer in the wake of nanoscience and nanotechnology.
Paolo Decuzzi   +22 more
openaire   +8 more sources

The consolidation of nanomedicine [PDF]

open access: yesWIREs Nanomedicine and Nanobiotechnology, 2019
AbstractOver the past two decades, nanomedicine has grown steadily, however, without inducing a palpable shift in the diagnosis and treatment of diseases so far. While this may simply be a consequence of the slow, incremental nature that characterizes many modern technologies, this article posits that there is another set of significant factors ...
Raphael Zingg   +2 more
openaire   +4 more sources

The success of nanomedicine [PDF]

open access: yesNano Today, 2020
In recent years, the promise and prospects of nanomedicine have been controversially discussed. We here argue that nanomedicine has undeniably been successful, not only academically and preclinically, but also industrially and clinically. To ensure that we keep on making progress, we have to move away from over-focusing on nano and on materials ...
Twan Lammers   +4 more
openaire   +3 more sources

Nanoproteomics for Nanomedicine [PDF]

open access: yesNanomedicine, 2010
677 ISSN 1743-5889 Nanomedicine (2010) 5(5), 677–682 10.2217/NNM.10.46 © 2010 Future Medicine Ltd “Label-free NAPPA technology, in combination with protein nanobiocrystallography and its possible future development using anodic porous alumina along with a cell-free expression system ...
NICOLINI, CLAUDIO, PESHKOVA, EVGENIYA
openaire   +4 more sources

A Recent Review on Cancer Nanomedicine

open access: yesCancers, 2023
Simple Summary The advancement of nanotechnology over the last three decades has given new hope to cancer management. The first FDA-approved nanomedicine (DOXIL) was made available in the market in 1995.
P. Giri   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy